154 related articles for article (PubMed ID: 32739935)
1. Neuroendocrine Carcinomas of the Gallbladder: A Clinicopathologic and Immunohistochemical Analysis of 34 Resected Cases.
Lee SM; Sung CO
Am J Surg Pathol; 2020 Oct; 44(10):1308-1321. PubMed ID: 32739935
[TBL] [Abstract][Full Text] [Related]
2. Gallbladder Mixed Neuroendocrine-Non-neuroendocrine Neoplasm (MiNEN) Arising in Intracholecystic Papillary Neoplasm: Clinicopathologic and Molecular Analysis of a Case and Review of the Literature.
Sciarra A; Missiaglia E; Trimech M; Melloul E; Brouland JP; Sempoux C; La Rosa S
Endocr Pathol; 2020 Mar; 31(1):84-93. PubMed ID: 31981075
[TBL] [Abstract][Full Text] [Related]
3. Gallbladder neuroendocrine carcinoma: report of 10 cases and comparision of clinicopathologic features with gallbladder adenocarcinoma.
Chen C; Wang L; Liu X; Zhang G; Zhao Y; Geng Z
Int J Clin Exp Pathol; 2015; 8(7):8218-26. PubMed ID: 26339390
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine Carcinoma of Gall Bladder: A Series of 19 Cases with Review of Literature.
Kamboj M; Gandhi JS; Gupta G; Sharma A; Pasricha S; Mehta A; Chandragouda D; Sinha R
J Gastrointest Cancer; 2015 Dec; 46(4):356-64. PubMed ID: 26208508
[TBL] [Abstract][Full Text] [Related]
5. Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival.
Olevian DC; Nikiforova MN; Chiosea S; Sun W; Bahary N; Kuan SF; Pai RK
Hum Pathol; 2016 Mar; 49():124-34. PubMed ID: 26826419
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of small cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder.
Yun SP; Shin N; Seo HI
World J Gastroenterol; 2015 Jan; 21(1):269-75. PubMed ID: 25574101
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic features of neuroendocrine carcinomas of the stomach: appraisal of small cell and large cell variants.
Matsui K; Jin XM; Kitagawa M; Miwa A
Arch Pathol Lab Med; 1998 Nov; 122(11):1010-7. PubMed ID: 9822131
[TBL] [Abstract][Full Text] [Related]
8. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
Tang LH; Basturk O; Sue JJ; Klimstra DS
Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
[TBL] [Abstract][Full Text] [Related]
9. Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are ≥1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases.
Adsay V; Jang KT; Roa JC; Dursun N; Ohike N; Bagci P; Basturk O; Bandyopadhyay S; Cheng JD; Sarmiento JM; Escalona OT; Goodman M; Kong SY; Terry P
Am J Surg Pathol; 2012 Sep; 36(9):1279-301. PubMed ID: 22895264
[TBL] [Abstract][Full Text] [Related]
10. Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors.
Yachida S; Vakiani E; White CM; Zhong Y; Saunders T; Morgan R; de Wilde RF; Maitra A; Hicks J; Demarzo AM; Shi C; Sharma R; Laheru D; Edil BH; Wolfgang CL; Schulick RD; Hruban RH; Tang LH; Klimstra DS; Iacobuzio-Donahue CA
Am J Surg Pathol; 2012 Feb; 36(2):173-84. PubMed ID: 22251937
[TBL] [Abstract][Full Text] [Related]
11. Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder.
Liu F; Li Y; Ying D; Qiu S; He Y; Li M; Liu Y; Zhang Y; Zhu Q; Hu Y; Liu L; Li G; Pan W; Jin W; Mu J; Cao Y; Liu Y
Signal Transduct Target Ther; 2021 Feb; 6(1):55. PubMed ID: 33563892
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathologic features of primary renal neuroendocrine carcinoma].
Wang XH; Lu X; He B; Jiang YX; Yu WJ; Wang H; Zhang W; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):851-856. PubMed ID: 30423609
[No Abstract] [Full Text] [Related]
13. Coexisting tubular adenoma with a neuroendocrine carcinoma of colon allowing early surgical intervention and implicating a shared stem cell origin.
Soliman ML; Tiwari A; Zhao Q
World J Gastroenterol; 2017 Feb; 23(6):1106-1112. PubMed ID: 28246485
[TBL] [Abstract][Full Text] [Related]
14. BRAF
Dizdar L; Werner TA; Drusenheimer JC; Möhlendick B; Raba K; Boeck I; Anlauf M; Schott M; Göring W; Esposito I; Stoecklein NH; Knoefel WT; Krieg A
Int J Cancer; 2019 Mar; 144(6):1379-1390. PubMed ID: 30144031
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine carcinoma of the stomach: morphologic and immunohistochemical characteristics and prognosis.
Ishida M; Sekine S; Fukagawa T; Ohashi M; Morita S; Taniguchi H; Katai H; Tsuda H; Kushima R
Am J Surg Pathol; 2013 Jul; 37(7):949-59. PubMed ID: 23759931
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of the coexisting precursor lesion types in invasive gallbladder cancer.
Mochidome N; Koga Y; Ohishi Y; Miyazaki T; Matsuda R; Yamada Y; Aishima S; Nakamura M; Oda Y
Hum Pathol; 2021 Aug; 114():44-53. PubMed ID: 33989638
[TBL] [Abstract][Full Text] [Related]
17. Retinoblastoma co-repressor 1 (RB) and cyclin-dependent kinase inhibitor (CDKN) as a multi-gene panel for differentiating pulmonary from non-pulmonary origin in metastatic neuroendocrine carcinomas.
Krishnamurthy K; Cusnir M; Schwartz M; Sriganeshan V; Poppiti RJ
Pathol Res Pract; 2020 Sep; 216(9):153051. PubMed ID: 32825935
[TBL] [Abstract][Full Text] [Related]
18. Molecular characteristics of colorectal neuroendocrine carcinoma; similarities with adenocarcinoma rather than neuroendocrine tumor.
Takizawa N; Ohishi Y; Hirahashi M; Takahashi S; Nakamura K; Tanaka M; Oki E; Takayanagi R; Oda Y
Hum Pathol; 2015 Dec; 46(12):1890-900. PubMed ID: 26434631
[TBL] [Abstract][Full Text] [Related]
19. Mixed adenoneuroendocrine carcinoma of the gallbladder, amphicrine type: Case report and review of literature.
Zhang D; Li P; Szankasi P; Liao X
Pathol Res Pract; 2020 Jul; 216(7):152997. PubMed ID: 32534704
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic Features and Surgical Outcomes of Neuroendocrine Carcinoma of the Gallbladder.
Tanioka N; Okabayashi T; Sui K; Matsumoto T; Iwata J; Morita S; Shimada Y
Surg Technol Int; 2019 May; 34():101-106. PubMed ID: 30888678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]